Ira E. Ritter

Insider Reports History

Location
C/O Ritter Pharmaceuticals Inc., 1801 Century Park East, Suite 1820, Los Angeles, CA
Signature
/s/ Ira E. Ritter
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ira E. Ritter:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Qualigen Therapeutics, Inc. Director Stock Option (Right to Buy) 40K Jul 11, 2022 Direct

Insider Reports Filed by Ira E. Ritter

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QLGN Qualigen Therapeutics, Inc. Jul 11, 2022 1 $0 4 Aug 4, 2022 Director